The Virtus LifeSci Biotech Clinical Trials fund, which trades under the ticker BBC, gained 22%, beating more than 1,970 rivals.

Cornerstone Capital Group is moving ahead with its first stock fund for individual investors with social and environmental goals.

A look at which ETFs and index providers are behind the strong growth in 2019.

And advisors might be to blame.

ETF assets make up a sliver of these asset managers’ overall business, but their own stock performance bears watching.

President Donald Trump said Tuesday that he saw no urgency to complete a trade deal with China.

The market is a meritocracy, and only the strongest survive.